The new direction of drug development: Degradation of undruggable targets through targeting chimera technology

X Liang, H Ren, F Han, R Liang… - Medicinal Research …, 2024 - Wiley Online Library
Imbalances in protein and noncoding RNA levels in vivo lead to the occurrence of many
diseases. In addition to the use of small molecule inhibitors and agonists to restore these …
被引用次数：2 相关文章

The new direction of drug development: Degradation of undruggable targets through targeting chimera technology

X Liang, H Ren, F Han, R Liang… - Medicinal research … - pubmed.ncbi.nlm.nih.gov
Imbalances in protein and noncoding RNA levels in vivo lead to the occurrence of many
diseases. In addition to the use of small molecule inhibitors and agonists to restore these …

The new direction of drug development: Degradation of undruggable targets through targeting chimera technology.

X Liang, H Ren, F Han, R Liang, J Zhao… - Medicinal Research …, 2023 - europepmc.org
Imbalances in protein and noncoding RNA levels in vivo lead to the occurrence of many
diseases. In addition to the use of small molecule inhibitors and agonists to restore these …